The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells

Z Zhao, S Chen, X Zhu, F Pan, R Li, Y Zhou, W Yuan… - Leukemia, 2016 - nature.com
Z Zhao, S Chen, X Zhu, F Pan, R Li, Y Zhou, W Yuan, H Ni, FC Yang, M Xu
Leukemia, 2016nature.com
3 Stelljes M, Krug U, Beelen DW, Braess J, Sauerland MC, Heineke A et al. Allogeneic
transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia:
a prospective matched pairs analysis. J Clin Oncol 2014; 32: 288-296. 4 Buchner T, Berdel
WE, Hiddemann W. Priming with granulocyte colonystimulating factor--relation to high-dose
cytarabine in acute myeloid leukemia.
3 Stelljes M, Krug U, Beelen DW, Braess J, Sauerland MC, Heineke A et al. Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis. J Clin Oncol 2014; 32: 288-296. 4 Buchner T, Berdel WE, Hiddemann W. Priming with granulocyte colonystimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.
nature.com